SeqOnce Biosciences Completes Relocation to Carlsbad, CA theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
New Research Facility to Advance GenomicsCARLSBAD, CA / ACCESSWIRE / January 19, 2023 / SeqOnce Biosciences, Inc., a genomics company creating new tools to detect and analyze human disease, is thrilled
Press release content from PR Newswire. The AP news staff was not involved in its creation.
SeqOnce Biosciences Announces AzureSeq RT-qPCR Assay to Detect SARS-CoV-2 E484K Variant of Concern
March 10, 2021 GMT
(PRNewsfoto/SeqOnce Biosciences, Inc.)
PASADENA, Calif., March 10, 2021 /PRNewswire/ SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 E484K variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR E484K kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene E484K (G23012A), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX. Using RT-qPCR to detect the SARS-CoV-2 E484K variant is faster and allows far more samples to be screened, compared to sequencing.
(0)
Assay quickly identifies the N501Y mutation found in U.K., South Africa and Brazil lineages of SARS-CoV-2
BUDAPEST, Hungary and PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ Omixon and SeqOnce Biosciences, Inc., announce today the launch of a new extension to the AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-Co-V2 RT-qPCR N501Y assay uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
Share this article
Share this article
PASADENA, Calif., Jan. 28, 2021 /PRNewswire/ SeqOnce Biosciences, Inc., announced today the launch of its new AzureSeq One-Step Universal RT-qPCR kit for the detection of the novel coronavirus SARS-CoV-2 N501Y variant. The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y kit uses a single-tube reaction targeting the N1 nucleocapsid gene, both alleles of S gene N501Y (A23063T), and includes RNaseP as a control. The assay uses common qPCR instruments with detection channels of FAM, HEX, Cy5, and ROX.
The AzureSeq One-Step Universal SARS-CoV-2 RT-qPCR N501Y assay does not require viral RNA extraction and has a rapid cycling protocol option, delivering sample to answer results in under 30 .